0001982296-23-000002.txt : 20231024 0001982296-23-000002.hdr.sgml : 20231024 20231024105726 ACCESSION NUMBER: 0001982296-23-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20231024 DATE AS OF CHANGE: 20231024 EFFECTIVENESS DATE: 20231024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVSF - Surge Therapeutics 2023, LLC CENTRAL INDEX KEY: 0001982296 IRS NUMBER: 924019622 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-484977 FILM NUMBER: 231341602 BUSINESS ADDRESS: STREET 1: 670 NORTH COMMERCIAL STREET STREET 2: SUITE 403 CITY: MANCHESTER STATE: NH ZIP: 03101 BUSINESS PHONE: 603-518-8112 MAIL ADDRESS: STREET 1: 70 FEDERAL STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 D/A 1 primary_doc.xml X0708 D/A LIVE 0001982296 AVSF - Surge Therapeutics 2023, LLC 70 Federal Street 6th Floor Boston MA MASSACHUSETTS 02110 603-518-8112 DELAWARE None None Limited Liability Company true 2023 Michael Collins 670 N. Commercial Street Suite 403 Manchester NH NEW HAMPSHIRE 03101 Executive Officer CEO of Alumni Ventures Group, the Issuers Sole Manager Pooled Investment Fund Venture Capital Fund false $1 - $1,000,000 06b 3C 3C.1 true 0001982296-23-000001 2023-06-09 false true true false 5000 None None None None N/A N/A N/A NH NEW HAMPSHIRE 03101 All States false 2931500 2931500 0 false 207 0 0 0 false AVSF - Surge Therapeutics 2023, LLC Hilary Ncala Hilary Ncala General Manager, Alumni Funds of Issuers Sole Manager 2023-10-24